Affilogic
Affilogic is a biotechnology company specialising in the discovery and development of its proprietary Nanofitin® affinity protein platform. Significantly smaller than antibodies and highly stable, Nanofitins® can be engineered as both therapeutic agents and targeted delivery vectors. The company is advancing a portfolio of programmes spanning CNS delivery, inhaled antivirals, gastrointestinal diseases, and oncology, while also supporting partners through its NanoVector platform for the targeted delivery of modalities such as ASOs, siRNA, antibodies, peptides, CAR-T therapies, and AAVs. Through these applications, Affilogic is demonstrating the versatility of Nanofitins® across multiple therapeutic areas and routes of administration.
